Harry O'Grady
Senior Vice President, Chief Financial Officer, Ipsen North America
Harry brings more than 30 years of business experience and a keen understanding of the pharmaceutical industry to his role as Chief Financial Officer for Ipsen North America.
Prior to joining Ipsen, Harry held Chief Financial Officer positions at CorMedix Inc. and Mylan Specialty. Harry previously oversaw Finance and Finance Operations for the Sterile Business Unit as a Vice President of Finance at Catalent Pharma Solutions. Before joining Catalent, Harry spent 13 years at Bayer HealthCare Pharmaceuticals Inc., in the roles of Vice President of Business Planning and Administration, Controller, and Executive Director for Managed Markets. At Bayer, he implemented an efficient global business unit model for a $2 billion business unit and spearheaded strategic and operative planning, portfolio analysis, business development support and integration.
Harry is a certified public accountant with a BBA in Accounting from Pace University and an MBA from Lehigh University.
Our mission?
To improve patients’ lives
Acting on this mission has propelled us to become a global biopharmaceutical leader with a focus on innovation and specialty care. We help patients through our expertise in oncology, neuroscience, and rare diseases.
Find out more about us or see other members of our leadership team.
About
Products and partnerships
Partnering
Access our development and commercialization teams. We take bold steps to translate your science and innovations into solutions that make a difference for patients in need.
See more on partneringProducts and partnerships
What’s happening now?